Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling.
Partition of signaling molecules in sphingolipid-cholesterol-enriched membrane domains, among which are the caveolae, may contribute to signal transduction efficiency. In normal thyroid, nothing is known about a putative TSH/cAMP cascade compartmentation in caveolae or other sphingolipid-cholesterol-enriched membrane domains. In this study we show for the first time that caveolae are present in the apical membrane of dog and human thyrocytes: caveolin-1 mRNA presence is demonstrated by Northern blotting in primary cultures and that of the caveolin-1 protein by immunohistochemistry performed on human thyroid tissue. The TSH receptor located in the basal membrane can therefore not be located in caveolae. We demonstrate for the first time by biochemical methods the existence of sphingolipid-cholesterol-enriched domains in human and dog thyroid follicular cells that contain caveolin, flotillin-2, and the insulin receptor. We assessed a possible sphingolipid-cholesterol-enriched domains compartmentation of the TSH receptor and the alpha- subunit of the heterotrimeric G(s) and G(q) proteins using two approaches: Western blotting on detergent-resistant membranes isolated from thyrocytes in primary cultures and the influence of 10 mm methyl-beta-cyclodextrin, a cholesterol chelator, on basal and stimulated cAMP accumulation in intact thyrocytes. The results from both types of experiments strongly suggest that the TSH/cAMP cascade in thyroid cells is not associated with sphingolipid-cholesterol-enriched membrane domains.
Costa
M J
MJ
Institute of Interdisciplinary Research, Free University of Brussels, School of Medicine, B-1070 Brussels, Belgium.
Song
Y
Y
Macours
P
P
Massart
C
C
Many
M C
MC
Costagliola
S
S
Dumont
J E
JE
Van Sande
J
J
Vanvooren
V
V
D000818:Animals; D016466:CHO Cells; D051242:Caveolin 1; D022461:Caveolins / Q000235:genetics / Q000378:metabolism; D002451:Cell Compartmentation / Q000502:physiology; D006224:Cricetinae; D003505:Cyclodextrins / Q000494:pharmacology; D003902:Detergents; D004285:Dogs; D043802:GTP-Binding Protein alpha Subunits, Gq-G11 / Q000378:metabolism; D019205:GTP-Binding Protein alpha Subunits, Gs / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D021962:Membrane Microdomains / Q000378:metabolism*; D008565:Membrane Proteins / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D011972:Receptor, Insulin / Q000378:metabolism; D011989:Receptors, Thyrotropin / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D013961:Thyroid Gland / Q000166:cytology / Q000378:metabolism*; D047392:beta-Cyclodextrins
C495540:CAV1 protein, human; D051242:Caveolin 1; D022461:Caveolins; D003505:Cyclodextrins; D003902:Detergents; D008565:Membrane Proteins; D012333:RNA, Messenger; D011989:Receptors, Thyrotropin; D047392:beta-Cyclodextrins; C106354:flotillins; C108732:methyl-beta-cyclodextrin; D011972:Receptor, Insulin; D043802:GTP-Binding Protein alpha Subunits, Gq-G11; D019205:GTP-Binding Protein alpha Subunits, Gs